Related by context. Frequent words. (Click for all words.) 81 Receives Orphan Drug Designation 81 Initiates Phase II 80 Presents Positive 77 Completes Enrollment 77 Files Shelf Registration Statement 76 Meets Primary Endpoint 75 please visit http:/www.supergen.com 75 FDA Accepts 75 Commences Phase 74 Announces FDA Clearance 74 FDA Clears 74 Jumps Higher 74 Inc Therapeutic Competitors 73 Q2 Loss Narrows 72 Drug Candidate 72 Initiates Phase 72 Develop Novel 72 Q3 Loss Narrows 72 Receives FDA Clearance 71 Q1 Loss Narrows 71 www.vivus.com 71 gets USFDA nod 71 Patient Enrollment 71 Invites Investors 71 Inc. Nasdaq IMGN 71 Initiate Phase 71 Pivotal Phase III 71 Drug Shows Promise 71 Q4 Loss Widens 71 Issues Guidance 71 BioGlue R 71 Clinical Trial Results 71 Q3 Loss Widens 70 Q4 Loss Narrows 70 Announces Presentation 70 Receives Notification 70 Q2 Loss Widens 70 Announces Initiation 70 Company Nasdaq PRGO 70 Completes Tender Offer 70 Phase III Clinical Trial 70 Improves Survival 69 Positive Opinion 69 Q1 Loss Widens 69 Shareholders Approve Acquisition 69 R sorafenib tablets 69 Updates Guidance 69 Achieves Milestone 69 Significantly Improves 69 Inhaled Insulin 69 Inc. NASDAQ QLTI 69 Inc. Nasdaq SUPG 69 submitted Biologics License 69 Q2 Profit Surges 69 Generic Version 69 http:/www.nabi.com 69 Preclinical Data 68 Puts Purchased 68 Cholesterol Drug 68 Recombinant Human 68 visit www.PAREXEL.com 68 Transcept Pharmaceuticals 68 Cyclacel Pharmaceuticals 68 Phase III Trial 68 Webcast Annual Meeting 68 Calls Purchased 68 MKC# 68 Announces Organizational Changes 68 BioMarin develops 68 Reduces Risk 68 Announces Issuance 68 Single Dose 68 Pivotal Trial 68 CRTX 68 www.incyte.com 68 Provides Guidance 68 Hold Fourth Quarter 68 Corp. Nasdaq GENZ 68 www.cardiome.com 67 Provides Shareholder 67 Seeks Approval 67 Nasdaq ADLR 67 www.combinatorx.com 67 Patent Issued 67 Receives Regulatory 67 Files Annual Report 67 Regains Compliance With 67 Reports Positive 67 Stockholders Approve Merger 67 ACADIA Pharmaceuticals 67 Patent Covering 67 Announces Stockholder Approval 67 FDA Approves 67 FDA Warns 67 ThermoDox R 67 Hold Third Quarter 67 www.syntapharma.com 67 DYAX 67 LGND 67 Application MAA 67 Small Molecule